tiprankstipranks
Advertisement
Advertisement
Fortress Biotech’s Cyprium enters agreement to sell PRV for $205M
PremiumThe FlyFortress Biotech’s Cyprium enters agreement to sell PRV for $205M
3M ago
Fortress Biotech Gains FDA Approval for Menkes Treatment
Premium
Company Announcements
Fortress Biotech Gains FDA Approval for Menkes Treatment
4M ago
Fortress Biotech, Cyprium announce FDA approval of ZYCUBO
Premium
The Fly
Fortress Biotech, Cyprium announce FDA approval of ZYCUBO
4M ago
Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
PremiumCompany AnnouncementsFortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
5M ago
Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
Premium
The Fly
Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
5M ago
Fortress Biotech price target raised to $4.50 from $4 at Alliance Global
Premium
The Fly
Fortress Biotech price target raised to $4.50 from $4 at Alliance Global
6M ago
Fortress subsidiary announces Crystalys dosed patient in study of dotinurad
PremiumThe FlyFortress subsidiary announces Crystalys dosed patient in study of dotinurad
7M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
8M ago
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100